187 related articles for article (PubMed ID: 38093847)
1. Novel Combination of Erythropoietin and Romiplostim to Treat Chemotherapy-Induced Anemia and Thrombocytopenia via Pharmacodynamic Interaction on Hematopoietic Stem and Progenitor Cells.
Fan X; Krzyzanski W; Wong RSM; Liu D; Yan X
ACS Pharmacol Transl Sci; 2023 Dec; 6(12):1884-1897. PubMed ID: 38093847
[TBL] [Abstract][Full Text] [Related]
2. Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic Progenitors.
Fan X; Krzyzanski W; Wong RSM; Yan X
J Pharmacol Exp Ther; 2022 Jul; 382(1):31-43. PubMed ID: 35489782
[TBL] [Abstract][Full Text] [Related]
3. A Novel Combination Therapy of Erythropoietin and Thrombopoietin to Treat Erythropoietin-Resistance anemia.
Zou H; Xu P; Wong RSM; Yan X
Pharm Res; 2022 Jun; 39(6):1249-1265. PubMed ID: 35661082
[TBL] [Abstract][Full Text] [Related]
4. Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia.
Fan X; Krzyzanski W; Liu D; Wong RSM; Yan X
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839666
[TBL] [Abstract][Full Text] [Related]
5. The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply.
Loo M; Beguin Y
Blood; 1999 May; 93(10):3286-93. PubMed ID: 10233880
[TBL] [Abstract][Full Text] [Related]
6. A Review of Romiplostim Mechanism of Action and Clinical Applicability.
Bussel JB; Soff G; Balduzzi A; Cooper N; Lawrence T; Semple JW
Drug Des Devel Ther; 2021; 15():2243-2268. PubMed ID: 34079225
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients.
Hartranft ME; Clemmons AB; DeRemer DL; Kota V
J Oncol Pharm Pract; 2017 Jan; 23(1):10-17. PubMed ID: 26471738
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of refractory secondary immune thrombocytopenia (antiphospholipid antibody syndrome-associated) with the combination of rituximab and romiplostim at the cost of severe bone pain: A case report and review of literature.
Yassa G; Shakir AR; Jagarlamudi K; Yassa AE
J Oncol Pharm Pract; 2021 Jan; 27(1):253-257. PubMed ID: 32611269
[TBL] [Abstract][Full Text] [Related]
10. Romiplostim for management of chemotherapy-induced thrombocytopenia.
Parameswaran R; Lunning M; Mantha S; Devlin S; Hamilton A; Schwartz G; Soff G
Support Care Cancer; 2014 May; 22(5):1217-22. PubMed ID: 24414994
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin and platelet production.
Beguin Y
Haematologica; 1999 Jun; 84(6):541-7. PubMed ID: 10366799
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
[TBL] [Abstract][Full Text] [Related]
13. [The role of human recombinant erythropoietin in oncologic surgery].
Mercuriali F
Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
[TBL] [Abstract][Full Text] [Related]
14. Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial.
Lee JW; Lee SE; Jung CW; Park S; Keta H; Park SK; Kim JA; Oh IH; Jang JH
Lancet Haematol; 2019 Nov; 6(11):e562-e572. PubMed ID: 31474546
[TBL] [Abstract][Full Text] [Related]
15. Severe romiplostim-induced rebound thrombocytopenia after splenectomy for refractory ITP.
Choe MJ; Packer CD
Ann Pharmacother; 2015 Jan; 49(1):140-4. PubMed ID: 25325908
[TBL] [Abstract][Full Text] [Related]
16. Romiplostim for thrombocytopenia following allogeneic stem cell transplantation: A case series.
Lancman G; Coltoff A; Steinberg A
Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):171-174. PubMed ID: 30030975
[TBL] [Abstract][Full Text] [Related]
17. Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats.
Soni HM; Vekaria AM; Rath AC; Belemkar S; Jain MR
Indian J Pharmacol; 2014; 46(3):328-33. PubMed ID: 24987182
[TBL] [Abstract][Full Text] [Related]
18. Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective.
Yang BB; Doshi S; Arkam K; Franklin J; Chow AT
Clin Pharmacokinet; 2016 Sep; 55(9):1045-58. PubMed ID: 27056734
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic model for chemotherapy-induced anemia in rats.
Woo S; Krzyzanski W; Jusko WJ
Cancer Chemother Pharmacol; 2008 Jun; 62(1):123-33. PubMed ID: 17891399
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
